India, Sept. 29 -- The following biotech stocks recorded notable moves on September 29, 2026, following key developments including positive preclinical data, a strategic investment, higher revenue guidance and encouraging clinical data.
Silexion Therapeutics Corp. (SLXN)
Silexion Therapeutics, a clinical-stage biotechnology company, is developing RNA interference (RNAi) therapies targeting KRAS-driven cancers, including locally advanced pancreatic cancer.
The company's stock surged over 30% on Tuesday after it reported positive preclinical findings supporting the systemic delivery and gene-silencing activity of SIL204.
Silexion said SIL204 demonstrated potent, dose-dependent knockdown of mutant KRAS expression in cancer cells in the pre...